| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
68,716 |
68,716 |
68,716 |
68,716 |
| Total Sell Value |
$961,682 |
$961,682 |
$961,682 |
$961,682 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
3 |
3 |
3 |
3 |
| End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mott David M |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
43,800 |
|
- |
|
| Alton Gregg H |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
|
- |
|
| King Rachel K. |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
10,050 |
|
- |
|
| Young James F |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,600 |
68,590 |
|
- |
|
| Douglas Richard |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
37,250 |
|
- |
|
| Mcglynn Margaret G |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$16,111 |
D/D |
(2,471) |
9,060 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$30,051 |
D/D |
4,609 |
11,531 |
|
- |
|
| Kelly James Patrick |
EVP, CFO and Treasurer |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$16,111 |
D/D |
(2,471) |
3,361 |
|
- |
|
| Kelly James Patrick |
EVP, CFO and Treasurer |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$30,051 |
D/D |
4,609 |
5,832 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$15,857 |
D/D |
(2,432) |
18,339 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$41,063 |
D/D |
6,298 |
20,771 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2023-03-10 |
4 |
B |
$6.50 |
$6,500 |
D/D |
1,000 |
14,473 |
2.74 |
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$11,606 |
D/D |
(1,780) |
11,278 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$30,051 |
D/D |
4,609 |
13,058 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2023-03-07 |
4 |
B |
$7.04 |
$14,088 |
D/D |
2,000 |
13,473 |
2.74 |
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2023-03-06 |
4 |
B |
$7.48 |
$22,454 |
D/D |
3,000 |
11,473 |
2.74 |
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2022-12-14 |
4 |
D |
$17.23 |
$39,974 |
D/D |
(2,320) |
36,492 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2022-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,966 |
38,812 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2022-12-14 |
4 |
D |
$17.23 |
$13,319 |
D/D |
(773) |
6,922 |
|
- |
|
| Trizzino John |
EVP, CCO and CBO |
• – – |
2022-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
7,695 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2022-12-14 |
4 |
D |
$17.23 |
$17,799 |
D/D |
(1,033) |
8,009 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2022-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
9,042 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2022-12-14 |
4 |
D |
$17.23 |
$12,061 |
D/D |
(700) |
8,449 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2022-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
9,149 |
|
- |
|
460 Records found
|
|
Page 3 of 19 |
|
|
